Home / World Marketplace / Archive by category Global Health & Biotech (Page 69)

Archive by category Global Health & Biotech

Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint

SHANGHAI, Jun. 11 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the primary endpoints of progression-free survival (“PFS,” based on independent radiographic review) and overall survival (“OS”) of a multi-center, randomized, open-label, [...]

Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials

– Lead Program, BPT567, will be the first PD1-IL18 immunoconjugate to enter the clinic; Phase 1/2a study in solid tumors expected to begin in 2H 2024 – – Financing led by Johnson & Johnson with participation by new and existing investors – BASEL, Switzerland and SAN DIEGO, June 11, 2024 (Korea Bizwire) – Bright Peak Therapeutics, [...]

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA SAN DIEGO, June 10, 2024 (Korea Bizwire) – In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: [...]

Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from BeiGene and remains eligible to receive up to $164 million based on additional milestones plus royalties on product sales A Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) [...]

Boehringer Ingelheim’s Survodutide Shows Breakthrough Improvement in Liver Fibrosis with No Worsening of MASH in 64.5% of Patients with F2 and F3 Fibrosis

News builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) versus placebo (18.2%). New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH.1 Additional sub-analysis shows [...]

Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions

BARCELONA, Spain and SAN FRANCISCO, June 05, 2024 (Korea Bizwire) – Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San Francisco-based, digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. This consolidation of two world-leading artificial intelligence-driven solutions providers marks a [...]

Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, New President of the EAACI

VALENCIA, Spain, June 04, 2024 (Korea Bizwire) – The Closing Ceremony of the EAACI Congress 2024, a meeting forum for experts in Allergy and Immunology from countries all over the world, has taken place. At the closing of the Congress, Dr. María José Torres, Professor of Medicine and Head of the Allergology Service of the Regional [...]

Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer

PHILADELPHIA, PA, June 04, 2024 (Korea Bizwire) – Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive. Antibody therapies called bispecific T cell engagers (BTEs) have emerged as effective treatments for some blood cancers [...]

Deep Integration of Proven AI Tools into Philips Cardiovascular Ultrasound Systems to Better Diagnose More Cardiac Disease Patients

New FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds First fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for [...]

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

DURHAM, N.C., June 04, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building [...]